The expression of Imatinib efflux (ABCB1, ABCG2) and influx (SLC22A1) transporters in CD34+ as well as bulk CML cells was compared. This evidence concerns the gene ABCG2 and chronic myelogenous leukemia, BCR-ABL1 positive.